Naoki Yoshimura - 19 Dec 2022 Form 3 Insider Report for LIPELLA PHARMACEUTICALS INC (LIPO)

Role
Director
Signature
/s/ Naoki Yoshimura
Issuer symbol
LIPO
Transactions as of
19 Dec 2022
Transactions value $
$0
Form type
3
Filing time
03 Jan 2023, 18:51:40 UTC
Next filing
21 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LIPO Stock Options 19 Dec 2022 Common Stock 4K $1.25 Direct F1
holding LIPO Stock Options 19 Dec 2022 Common Stock 10K $5.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Number of shares of Common Stock beneficially owned consists of 4,000 shares of Common Stock issuable upon the exercise of stock options held by the Reporting Person, which are exercisable for shares of Common Stock at a price of $1.25 per share.
F2 Number of shares of Common Stock beneficially owned consists of 10,000 shares of Common Stock issuable upon the exercise of stock options held by the Reporting Person, which are exercisable for shares of Common Stock at a price of $5.00 per share.